WHYY14h
Study finds access to lifesaving medication for opioid addiction in Philadelphia remains uneven
A researcher posed as a case manager and called treatment providers across the city to figure out how easy it is to get ...
Us Weekly2dOpinion
Psychiatry Professor Dr. Paula Riggs Weighs In On Recognizing and Treating Co-Occurring Disorders
Psychiatry professor Dr. Paula Riggs exclusively shared how to recognize and treat co-occurring disorders in Us Weekly's 'The ...
Mena FN17d
Polyrizon Launches Preclinical Studies For Intranasal Naloxone To Combat Opioid Overdose Using Cutting-Edge Platform
(MENAFN- GlobeNewsWire - Nasdaq) Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage ...
Business Insider17d
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
manilatimes18d
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
Raanana, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
IEEE18d
A Rapid, Pulsed Laser Testing Approach for Single Event Latch-up Screening
Abstract: Sandia National Laboratories (SNL) has developed a custom pulsed laser single event effects testing facility utilizing a tunable wavelength (680-1080 nm), 140 fs, 80 MHz, Ti:Sapphire laser.
Burnaby Now19d
Senators minority owners join others in expanded Ottawa Rapid ownership group
Northern Super League co-founder Diana Matheson is shown in a handout photo. Ottawa Rapid FC, whose owners include Northern Super League co-founders Matheson and Thomas Gilbert, has fleshed out its ...
Taiwan News20d
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Raanana, Israel, March 10, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative ...
Investing20d
Polyrizon begins preclinical studies for nasal opioid overdose treatment
RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a micro-cap biotech firm with a market capitalization of $3.46 million focused on developing nasal hydrogels, has launched preclinical studies for an ...